Trials / Completed
CompletedNCT02382016
PORtopulmonary Hypertension Treatment wIth maCitentan - a randOmized Clinical Trial
A Randomized, Double-blind, Placebo-controlled, Prospective, Multicenter, Parallel Group Study to Assess the Safety and Efficacy of Macitentan in Patients With Portopulmonary Hypertension
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 85 (actual)
- Sponsor
- Actelion · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
24-week study to evaluate the efficacy and safety of macitentan for the treatment of portopulmonary hypertension.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Macitentan | Macitentan film-coated tablet 10 mg once daily. |
| OTHER | Placebo | Matching placebo tablet once daily. |
Timeline
- Start date
- 2015-06-23
- Primary completion
- 2017-10-25
- Completion
- 2018-10-31
- First posted
- 2015-03-06
- Last updated
- 2025-03-30
- Results posted
- 2018-11-23
Locations
52 sites across 7 countries: United States, Brazil, Czechia, France, Germany, Spain, United Kingdom
Source: ClinicalTrials.gov record NCT02382016. Inclusion in this directory is not an endorsement.